nodes	percent_of_prediction	percent_of_DWPC	metapath
Lacosamide—Balance disorder—Vandetanib—thyroid cancer	0.0307	0.0404	CcSEcCtD
Lacosamide—CA6—saliva-secreting gland—thyroid cancer	0.023	0.103	CbGeAlD
Lacosamide—Proteinuria—Vandetanib—thyroid cancer	0.0191	0.0251	CcSEcCtD
Lacosamide—Protein urine present—Vandetanib—thyroid cancer	0.0189	0.0248	CcSEcCtD
Lacosamide—CA3—thyroid gland—thyroid cancer	0.0133	0.0597	CbGeAlD
Lacosamide—Proteinuria—Sorafenib—thyroid cancer	0.0129	0.0169	CcSEcCtD
Lacosamide—Atrial fibrillation—Vandetanib—thyroid cancer	0.0129	0.0169	CcSEcCtD
Lacosamide—Protein urine present—Sorafenib—thyroid cancer	0.0127	0.0167	CcSEcCtD
Lacosamide—CA6—head—thyroid cancer	0.0125	0.0559	CbGeAlD
Lacosamide—CA4—neck—thyroid cancer	0.0123	0.055	CbGeAlD
Lacosamide—CA3—head—thyroid cancer	0.0118	0.0529	CbGeAlD
Lacosamide—Drug hypersensitivity—Epirubicin—thyroid cancer	0.0104	0.0137	CcSEcCtD
Lacosamide—CA2—neck—thyroid cancer	0.0102	0.0456	CbGeAlD
Lacosamide—Neutropenia—Vandetanib—thyroid cancer	0.00986	0.0129	CcSEcCtD
Lacosamide—Drug hypersensitivity—Doxorubicin—thyroid cancer	0.00962	0.0126	CcSEcCtD
Lacosamide—CA4—saliva-secreting gland—thyroid cancer	0.00957	0.0429	CbGeAlD
Lacosamide—Depression—Vandetanib—thyroid cancer	0.00937	0.0123	CcSEcCtD
Lacosamide—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.00932	0.0122	CcSEcCtD
Lacosamide—Hepatobiliary disease—Vandetanib—thyroid cancer	0.00889	0.0117	CcSEcCtD
Lacosamide—Bradycardia—Vandetanib—thyroid cancer	0.00859	0.0113	CcSEcCtD
Lacosamide—CA5B—thyroid gland—thyroid cancer	0.00846	0.0379	CbGeAlD
Lacosamide—CA3—lymph node—thyroid cancer	0.00827	0.0371	CbGeAlD
Lacosamide—SCN3A—thyroid gland—thyroid cancer	0.00822	0.0368	CbGeAlD
Lacosamide—SCN10A—head—thyroid cancer	0.008	0.0359	CbGeAlD
Lacosamide—Erythema multiforme—Vandetanib—thyroid cancer	0.00798	0.0105	CcSEcCtD
Lacosamide—CA2—saliva-secreting gland—thyroid cancer	0.00794	0.0355	CbGeAlD
Lacosamide—Eye disorder—Vandetanib—thyroid cancer	0.00789	0.0104	CcSEcCtD
Lacosamide—Cardiac disorder—Vandetanib—thyroid cancer	0.00783	0.0103	CcSEcCtD
Lacosamide—Mood swings—Sorafenib—thyroid cancer	0.0078	0.0102	CcSEcCtD
Lacosamide—CA5B—head—thyroid cancer	0.00751	0.0336	CbGeAlD
Lacosamide—Toxic epidermal necrolysis—Sorafenib—thyroid cancer	0.00741	0.00973	CcSEcCtD
Lacosamide—Mental disorder—Vandetanib—thyroid cancer	0.00739	0.00971	CcSEcCtD
Lacosamide—CA4—trachea—thyroid cancer	0.00738	0.0331	CbGeAlD
Lacosamide—SCN9A—lymph node—thyroid cancer	0.00736	0.033	CbGeAlD
Lacosamide—SCN3A—head—thyroid cancer	0.00729	0.0327	CbGeAlD
Lacosamide—Muscle spasms—Vandetanib—thyroid cancer	0.00706	0.00928	CcSEcCtD
Lacosamide—Vision blurred—Vandetanib—thyroid cancer	0.00692	0.00909	CcSEcCtD
Lacosamide—Tremor—Vandetanib—thyroid cancer	0.00688	0.00904	CcSEcCtD
Lacosamide—Neutropenia—Sorafenib—thyroid cancer	0.00665	0.00873	CcSEcCtD
Lacosamide—CA1—head—thyroid cancer	0.00663	0.0297	CbGeAlD
Lacosamide—Loss of consciousness—Vandetanib—thyroid cancer	0.00646	0.00848	CcSEcCtD
Lacosamide—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.00629	0.00826	CcSEcCtD
Lacosamide—Chest pain—Vandetanib—thyroid cancer	0.00625	0.00821	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00621	0.00816	CcSEcCtD
Lacosamide—CA2—trachea—thyroid cancer	0.00612	0.0274	CbGeAlD
Lacosamide—Dry mouth—Vandetanib—thyroid cancer	0.00612	0.00803	CcSEcCtD
Lacosamide—Hepatobiliary disease—Sorafenib—thyroid cancer	0.006	0.00788	CcSEcCtD
Lacosamide—Nervous system disorder—Vandetanib—thyroid cancer	0.00588	0.00772	CcSEcCtD
Lacosamide—Nystagmus—Epirubicin—thyroid cancer	0.00587	0.0077	CcSEcCtD
Lacosamide—CA4—thyroid gland—thyroid cancer	0.00584	0.0262	CbGeAlD
Lacosamide—Skin disorder—Vandetanib—thyroid cancer	0.00582	0.00765	CcSEcCtD
Lacosamide—SCN10A—lymph node—thyroid cancer	0.0056	0.0251	CbGeAlD
Lacosamide—Connective tissue disorder—Sorafenib—thyroid cancer	0.00559	0.00735	CcSEcCtD
Lacosamide—Nystagmus—Doxorubicin—thyroid cancer	0.00543	0.00713	CcSEcCtD
Lacosamide—Insomnia—Vandetanib—thyroid cancer	0.00542	0.00712	CcSEcCtD
Lacosamide—Paraesthesia—Vandetanib—thyroid cancer	0.00538	0.00707	CcSEcCtD
Lacosamide—Erythema multiforme—Sorafenib—thyroid cancer	0.00538	0.00707	CcSEcCtD
Lacosamide—Tinnitus—Sorafenib—thyroid cancer	0.00531	0.00697	CcSEcCtD
Lacosamide—Cardiac disorder—Sorafenib—thyroid cancer	0.00528	0.00694	CcSEcCtD
Lacosamide—Dyspepsia—Vandetanib—thyroid cancer	0.00528	0.00693	CcSEcCtD
Lacosamide—CA5B—lymph node—thyroid cancer	0.00526	0.0235	CbGeAlD
Lacosamide—CA4—head—thyroid cancer	0.00518	0.0232	CbGeAlD
Lacosamide—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00518	0.0068	CcSEcCtD
Lacosamide—Fatigue—Vandetanib—thyroid cancer	0.00517	0.00679	CcSEcCtD
Lacosamide—Immune system disorder—Sorafenib—thyroid cancer	0.00514	0.00675	CcSEcCtD
Lacosamide—Injection site pain—Epirubicin—thyroid cancer	0.00513	0.00674	CcSEcCtD
Lacosamide—Constipation—Vandetanib—thyroid cancer	0.00513	0.00673	CcSEcCtD
Lacosamide—SCN3A—lymph node—thyroid cancer	0.00511	0.0229	CbGeAlD
Lacosamide—Blood disorder—Epirubicin—thyroid cancer	0.00502	0.00659	CcSEcCtD
Lacosamide—Mental disorder—Sorafenib—thyroid cancer	0.00499	0.00655	CcSEcCtD
Lacosamide—Erythema—Sorafenib—thyroid cancer	0.00496	0.00651	CcSEcCtD
Lacosamide—CA2—thyroid gland—thyroid cancer	0.00484	0.0217	CbGeAlD
Lacosamide—Muscle spasms—Sorafenib—thyroid cancer	0.00476	0.00626	CcSEcCtD
Lacosamide—Injection site pain—Doxorubicin—thyroid cancer	0.00475	0.00624	CcSEcCtD
Lacosamide—Body temperature increased—Vandetanib—thyroid cancer	0.00474	0.00622	CcSEcCtD
Lacosamide—CA1—lymph node—thyroid cancer	0.00464	0.0208	CbGeAlD
Lacosamide—Blood disorder—Doxorubicin—thyroid cancer	0.00464	0.00609	CcSEcCtD
Lacosamide—Anaemia—Sorafenib—thyroid cancer	0.00458	0.00601	CcSEcCtD
Lacosamide—Angioedema—Sorafenib—thyroid cancer	0.00453	0.00595	CcSEcCtD
Lacosamide—Syncope—Sorafenib—thyroid cancer	0.00444	0.00584	CcSEcCtD
Lacosamide—Dysarthria—Epirubicin—thyroid cancer	0.00443	0.00582	CcSEcCtD
Lacosamide—Loss of consciousness—Sorafenib—thyroid cancer	0.00436	0.00572	CcSEcCtD
Lacosamide—Atrioventricular block—Epirubicin—thyroid cancer	0.00432	0.00567	CcSEcCtD
Lacosamide—Asthenia—Vandetanib—thyroid cancer	0.0043	0.00565	CcSEcCtD
Lacosamide—CA2—head—thyroid cancer	0.0043	0.0192	CbGeAlD
Lacosamide—Gait disturbance—Epirubicin—thyroid cancer	0.00429	0.00564	CcSEcCtD
Lacosamide—Coordination abnormal—Epirubicin—thyroid cancer	0.00427	0.0056	CcSEcCtD
Lacosamide—Pruritus—Vandetanib—thyroid cancer	0.00424	0.00557	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00419	0.0055	CcSEcCtD
Lacosamide—Dry mouth—Sorafenib—thyroid cancer	0.00413	0.00542	CcSEcCtD
Lacosamide—Diarrhoea—Vandetanib—thyroid cancer	0.0041	0.00539	CcSEcCtD
Lacosamide—Dysarthria—Doxorubicin—thyroid cancer	0.0041	0.00538	CcSEcCtD
Lacosamide—Atrioventricular block—Doxorubicin—thyroid cancer	0.004	0.00525	CcSEcCtD
Lacosamide—Shock—Sorafenib—thyroid cancer	0.00398	0.00523	CcSEcCtD
Lacosamide—Gait disturbance—Doxorubicin—thyroid cancer	0.00397	0.00522	CcSEcCtD
Lacosamide—Nervous system disorder—Sorafenib—thyroid cancer	0.00397	0.00521	CcSEcCtD
Lacosamide—Dizziness—Vandetanib—thyroid cancer	0.00397	0.00521	CcSEcCtD
Lacosamide—Coordination abnormal—Doxorubicin—thyroid cancer	0.00395	0.00518	CcSEcCtD
Lacosamide—Skin disorder—Sorafenib—thyroid cancer	0.00393	0.00516	CcSEcCtD
Lacosamide—Vomiting—Vandetanib—thyroid cancer	0.00381	0.00501	CcSEcCtD
Lacosamide—Rash—Vandetanib—thyroid cancer	0.00378	0.00496	CcSEcCtD
Lacosamide—Dermatitis—Vandetanib—thyroid cancer	0.00378	0.00496	CcSEcCtD
Lacosamide—Headache—Vandetanib—thyroid cancer	0.00376	0.00493	CcSEcCtD
Lacosamide—CA4—lymph node—thyroid cancer	0.00363	0.0163	CbGeAlD
Lacosamide—Nausea—Vandetanib—thyroid cancer	0.00356	0.00468	CcSEcCtD
Lacosamide—Dyspepsia—Sorafenib—thyroid cancer	0.00356	0.00468	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00349	0.00459	CcSEcCtD
Lacosamide—Fatigue—Sorafenib—thyroid cancer	0.00349	0.00458	CcSEcCtD
Lacosamide—Constipation—Sorafenib—thyroid cancer	0.00346	0.00454	CcSEcCtD
Lacosamide—Urticaria—Sorafenib—thyroid cancer	0.00321	0.00422	CcSEcCtD
Lacosamide—Body temperature increased—Sorafenib—thyroid cancer	0.0032	0.0042	CcSEcCtD
Lacosamide—Diplopia—Epirubicin—thyroid cancer	0.00304	0.00399	CcSEcCtD
Lacosamide—Osteoarthritis—Epirubicin—thyroid cancer	0.00304	0.00399	CcSEcCtD
Lacosamide—CA2—lymph node—thyroid cancer	0.00301	0.0135	CbGeAlD
Lacosamide—Affect lability—Epirubicin—thyroid cancer	0.00299	0.00393	CcSEcCtD
Lacosamide—Hypersensitivity—Sorafenib—thyroid cancer	0.00298	0.00391	CcSEcCtD
Lacosamide—Asthenia—Sorafenib—thyroid cancer	0.0029	0.00381	CcSEcCtD
Lacosamide—Mood swings—Epirubicin—thyroid cancer	0.00288	0.00378	CcSEcCtD
Lacosamide—Pruritus—Sorafenib—thyroid cancer	0.00286	0.00376	CcSEcCtD
Lacosamide—Ataxia—Epirubicin—thyroid cancer	0.00286	0.00376	CcSEcCtD
Lacosamide—Diplopia—Doxorubicin—thyroid cancer	0.00281	0.0037	CcSEcCtD
Lacosamide—Osteoarthritis—Doxorubicin—thyroid cancer	0.00281	0.0037	CcSEcCtD
Lacosamide—Liver function test abnormal—Epirubicin—thyroid cancer	0.00281	0.00369	CcSEcCtD
Lacosamide—Affect lability—Doxorubicin—thyroid cancer	0.00277	0.00364	CcSEcCtD
Lacosamide—Diarrhoea—Sorafenib—thyroid cancer	0.00277	0.00363	CcSEcCtD
Lacosamide—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00274	0.0036	CcSEcCtD
Lacosamide—Dizziness—Sorafenib—thyroid cancer	0.00267	0.00351	CcSEcCtD
Lacosamide—Mood swings—Doxorubicin—thyroid cancer	0.00267	0.0035	CcSEcCtD
Lacosamide—Ataxia—Doxorubicin—thyroid cancer	0.00265	0.00347	CcSEcCtD
Lacosamide—Eosinophilia—Epirubicin—thyroid cancer	0.0026	0.00342	CcSEcCtD
Lacosamide—Liver function test abnormal—Doxorubicin—thyroid cancer	0.0026	0.00341	CcSEcCtD
Lacosamide—Vomiting—Sorafenib—thyroid cancer	0.00257	0.00338	CcSEcCtD
Lacosamide—Rash—Sorafenib—thyroid cancer	0.00255	0.00335	CcSEcCtD
Lacosamide—Dermatitis—Sorafenib—thyroid cancer	0.00255	0.00335	CcSEcCtD
Lacosamide—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.00253	0.00333	CcSEcCtD
Lacosamide—Headache—Sorafenib—thyroid cancer	0.00253	0.00333	CcSEcCtD
Lacosamide—Neutropenia—Epirubicin—thyroid cancer	0.00246	0.00323	CcSEcCtD
Lacosamide—Eosinophilia—Doxorubicin—thyroid cancer	0.00241	0.00316	CcSEcCtD
Lacosamide—Nausea—Sorafenib—thyroid cancer	0.0024	0.00315	CcSEcCtD
Lacosamide—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.00232	0.00305	CcSEcCtD
Lacosamide—Neutropenia—Doxorubicin—thyroid cancer	0.00227	0.00299	CcSEcCtD
Lacosamide—Hepatobiliary disease—Epirubicin—thyroid cancer	0.00222	0.00291	CcSEcCtD
Lacosamide—Agranulocytosis—Epirubicin—thyroid cancer	0.00219	0.00287	CcSEcCtD
Lacosamide—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.00215	0.00282	CcSEcCtD
Lacosamide—Bradycardia—Epirubicin—thyroid cancer	0.00214	0.00281	CcSEcCtD
Lacosamide—Hepatitis—Epirubicin—thyroid cancer	0.0021	0.00276	CcSEcCtD
Lacosamide—Hypoaesthesia—Epirubicin—thyroid cancer	0.00209	0.00275	CcSEcCtD
Lacosamide—Connective tissue disorder—Epirubicin—thyroid cancer	0.00207	0.00271	CcSEcCtD
Lacosamide—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.00205	0.00269	CcSEcCtD
Lacosamide—Agranulocytosis—Doxorubicin—thyroid cancer	0.00202	0.00266	CcSEcCtD
Lacosamide—Erythema multiforme—Epirubicin—thyroid cancer	0.00199	0.00261	CcSEcCtD
Lacosamide—Bradycardia—Doxorubicin—thyroid cancer	0.00198	0.0026	CcSEcCtD
Lacosamide—Eye disorder—Epirubicin—thyroid cancer	0.00197	0.00258	CcSEcCtD
Lacosamide—Tinnitus—Epirubicin—thyroid cancer	0.00196	0.00258	CcSEcCtD
Lacosamide—Cardiac disorder—Epirubicin—thyroid cancer	0.00195	0.00256	CcSEcCtD
Lacosamide—Hepatitis—Doxorubicin—thyroid cancer	0.00195	0.00256	CcSEcCtD
Lacosamide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—EPO—thyroid cancer	0.00195	0.128	CbGpPWpGaD
Lacosamide—Hypoaesthesia—Doxorubicin—thyroid cancer	0.00194	0.00254	CcSEcCtD
Lacosamide—Connective tissue disorder—Doxorubicin—thyroid cancer	0.00191	0.00251	CcSEcCtD
Lacosamide—Immune system disorder—Epirubicin—thyroid cancer	0.0019	0.0025	CcSEcCtD
Lacosamide—Mental disorder—Epirubicin—thyroid cancer	0.00184	0.00242	CcSEcCtD
Lacosamide—Erythema multiforme—Doxorubicin—thyroid cancer	0.00184	0.00242	CcSEcCtD
Lacosamide—Erythema—Epirubicin—thyroid cancer	0.00183	0.00241	CcSEcCtD
Lacosamide—Eye disorder—Doxorubicin—thyroid cancer	0.00182	0.00239	CcSEcCtD
Lacosamide—Tinnitus—Doxorubicin—thyroid cancer	0.00182	0.00238	CcSEcCtD
Lacosamide—Cardiac disorder—Doxorubicin—thyroid cancer	0.00181	0.00237	CcSEcCtD
Lacosamide—Flatulence—Epirubicin—thyroid cancer	0.0018	0.00237	CcSEcCtD
Lacosamide—Muscle spasms—Epirubicin—thyroid cancer	0.00176	0.00231	CcSEcCtD
Lacosamide—Immune system disorder—Doxorubicin—thyroid cancer	0.00176	0.00231	CcSEcCtD
Lacosamide—Vision blurred—Epirubicin—thyroid cancer	0.00173	0.00227	CcSEcCtD
Lacosamide—Mental disorder—Doxorubicin—thyroid cancer	0.00171	0.00224	CcSEcCtD
Lacosamide—Erythema—Doxorubicin—thyroid cancer	0.00169	0.00223	CcSEcCtD
Lacosamide—Anaemia—Epirubicin—thyroid cancer	0.00169	0.00222	CcSEcCtD
Lacosamide—Agitation—Epirubicin—thyroid cancer	0.00168	0.00221	CcSEcCtD
Lacosamide—Flatulence—Doxorubicin—thyroid cancer	0.00167	0.00219	CcSEcCtD
Lacosamide—Vertigo—Epirubicin—thyroid cancer	0.00165	0.00216	CcSEcCtD
Lacosamide—Syncope—Epirubicin—thyroid cancer	0.00164	0.00216	CcSEcCtD
Lacosamide—Muscle spasms—Doxorubicin—thyroid cancer	0.00163	0.00214	CcSEcCtD
Lacosamide—Palpitations—Epirubicin—thyroid cancer	0.00162	0.00213	CcSEcCtD
Lacosamide—Loss of consciousness—Epirubicin—thyroid cancer	0.00161	0.00211	CcSEcCtD
Lacosamide—Vision blurred—Doxorubicin—thyroid cancer	0.0016	0.0021	CcSEcCtD
Lacosamide—Anaemia—Doxorubicin—thyroid cancer	0.00157	0.00206	CcSEcCtD
Lacosamide—Chest pain—Epirubicin—thyroid cancer	0.00156	0.00205	CcSEcCtD
Lacosamide—Agitation—Doxorubicin—thyroid cancer	0.00156	0.00205	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00155	0.00203	CcSEcCtD
Lacosamide—Discomfort—Epirubicin—thyroid cancer	0.00154	0.00202	CcSEcCtD
Lacosamide—Dry mouth—Epirubicin—thyroid cancer	0.00152	0.002	CcSEcCtD
Lacosamide—Vertigo—Doxorubicin—thyroid cancer	0.00152	0.002	CcSEcCtD
Lacosamide—Syncope—Doxorubicin—thyroid cancer	0.00152	0.002	CcSEcCtD
Lacosamide—Confusional state—Epirubicin—thyroid cancer	0.00151	0.00198	CcSEcCtD
Lacosamide—Palpitations—Doxorubicin—thyroid cancer	0.0015	0.00197	CcSEcCtD
Lacosamide—Loss of consciousness—Doxorubicin—thyroid cancer	0.00149	0.00196	CcSEcCtD
Lacosamide—Shock—Epirubicin—thyroid cancer	0.00147	0.00193	CcSEcCtD
Lacosamide—Nervous system disorder—Epirubicin—thyroid cancer	0.00147	0.00192	CcSEcCtD
Lacosamide—Skin disorder—Epirubicin—thyroid cancer	0.00145	0.00191	CcSEcCtD
Lacosamide—Hyperhidrosis—Epirubicin—thyroid cancer	0.00145	0.0019	CcSEcCtD
Lacosamide—Chest pain—Doxorubicin—thyroid cancer	0.00144	0.00189	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.00143	0.00188	CcSEcCtD
Lacosamide—Discomfort—Doxorubicin—thyroid cancer	0.00143	0.00187	CcSEcCtD
Lacosamide—Dry mouth—Doxorubicin—thyroid cancer	0.00141	0.00185	CcSEcCtD
Lacosamide—Confusional state—Doxorubicin—thyroid cancer	0.00139	0.00183	CcSEcCtD
Lacosamide—Shock—Doxorubicin—thyroid cancer	0.00136	0.00179	CcSEcCtD
Lacosamide—Nervous system disorder—Doxorubicin—thyroid cancer	0.00136	0.00178	CcSEcCtD
Lacosamide—Insomnia—Epirubicin—thyroid cancer	0.00135	0.00178	CcSEcCtD
Lacosamide—Skin disorder—Doxorubicin—thyroid cancer	0.00134	0.00176	CcSEcCtD
Lacosamide—Paraesthesia—Epirubicin—thyroid cancer	0.00134	0.00176	CcSEcCtD
Lacosamide—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00134	0.00176	CcSEcCtD
Lacosamide—Somnolence—Epirubicin—thyroid cancer	0.00133	0.00174	CcSEcCtD
Lacosamide—Dyspepsia—Epirubicin—thyroid cancer	0.00132	0.00173	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00129	0.00169	CcSEcCtD
Lacosamide—Fatigue—Epirubicin—thyroid cancer	0.00129	0.00169	CcSEcCtD
Lacosamide—Constipation—Epirubicin—thyroid cancer	0.00128	0.00168	CcSEcCtD
Lacosamide—Insomnia—Doxorubicin—thyroid cancer	0.00125	0.00164	CcSEcCtD
Lacosamide—Paraesthesia—Doxorubicin—thyroid cancer	0.00124	0.00163	CcSEcCtD
Lacosamide—Feeling abnormal—Epirubicin—thyroid cancer	0.00123	0.00162	CcSEcCtD
Lacosamide—Somnolence—Doxorubicin—thyroid cancer	0.00123	0.00161	CcSEcCtD
Lacosamide—Dyspepsia—Doxorubicin—thyroid cancer	0.00122	0.0016	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00119	0.00157	CcSEcCtD
Lacosamide—Fatigue—Doxorubicin—thyroid cancer	0.00119	0.00157	CcSEcCtD
Lacosamide—Urticaria—Epirubicin—thyroid cancer	0.00119	0.00156	CcSEcCtD
Lacosamide—Constipation—Doxorubicin—thyroid cancer	0.00118	0.00155	CcSEcCtD
Lacosamide—Body temperature increased—Epirubicin—thyroid cancer	0.00118	0.00155	CcSEcCtD
Lacosamide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—HIF1A—thyroid cancer	0.00116	0.0761	CbGpPWpGaD
Lacosamide—Feeling abnormal—Doxorubicin—thyroid cancer	0.00114	0.0015	CcSEcCtD
Lacosamide—Hypersensitivity—Epirubicin—thyroid cancer	0.0011	0.00145	CcSEcCtD
Lacosamide—Urticaria—Doxorubicin—thyroid cancer	0.0011	0.00144	CcSEcCtD
Lacosamide—Body temperature increased—Doxorubicin—thyroid cancer	0.00109	0.00144	CcSEcCtD
Lacosamide—Asthenia—Epirubicin—thyroid cancer	0.00107	0.00141	CcSEcCtD
Lacosamide—Pruritus—Epirubicin—thyroid cancer	0.00106	0.00139	CcSEcCtD
Lacosamide—Diarrhoea—Epirubicin—thyroid cancer	0.00102	0.00134	CcSEcCtD
Lacosamide—Hypersensitivity—Doxorubicin—thyroid cancer	0.00102	0.00134	CcSEcCtD
Lacosamide—Asthenia—Doxorubicin—thyroid cancer	0.000992	0.0013	CcSEcCtD
Lacosamide—Dizziness—Epirubicin—thyroid cancer	0.000988	0.0013	CcSEcCtD
Lacosamide—Pruritus—Doxorubicin—thyroid cancer	0.000979	0.00128	CcSEcCtD
Lacosamide—Vomiting—Epirubicin—thyroid cancer	0.00095	0.00125	CcSEcCtD
Lacosamide—Diarrhoea—Doxorubicin—thyroid cancer	0.000946	0.00124	CcSEcCtD
Lacosamide—Rash—Epirubicin—thyroid cancer	0.000942	0.00124	CcSEcCtD
Lacosamide—Dermatitis—Epirubicin—thyroid cancer	0.000942	0.00124	CcSEcCtD
Lacosamide—Headache—Epirubicin—thyroid cancer	0.000936	0.00123	CcSEcCtD
Lacosamide—Dizziness—Doxorubicin—thyroid cancer	0.000915	0.0012	CcSEcCtD
Lacosamide—Nausea—Epirubicin—thyroid cancer	0.000888	0.00117	CcSEcCtD
Lacosamide—Vomiting—Doxorubicin—thyroid cancer	0.000879	0.00115	CcSEcCtD
Lacosamide—Rash—Doxorubicin—thyroid cancer	0.000872	0.00115	CcSEcCtD
Lacosamide—Dermatitis—Doxorubicin—thyroid cancer	0.000871	0.00114	CcSEcCtD
Lacosamide—Headache—Doxorubicin—thyroid cancer	0.000866	0.00114	CcSEcCtD
Lacosamide—CA9—Cellular response to hypoxia—EPO—thyroid cancer	0.000859	0.0564	CbGpPWpGaD
Lacosamide—Nausea—Doxorubicin—thyroid cancer	0.000822	0.00108	CcSEcCtD
Lacosamide—CA9—Cellular response to hypoxia—HIF1A—thyroid cancer	0.000511	0.0336	CbGpPWpGaD
Lacosamide—CA9—HIF-1-alpha transcription factor network—CP—thyroid cancer	0.000504	0.0331	CbGpPWpGaD
Lacosamide—CA9—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.000395	0.026	CbGpPWpGaD
Lacosamide—CA3—Metabolism—MINPP1—thyroid cancer	0.000309	0.0203	CbGpPWpGaD
Lacosamide—CA3—Metabolism—NDUFA13—thyroid cancer	0.000263	0.0173	CbGpPWpGaD
Lacosamide—CA3—Metabolism—CHST14—thyroid cancer	0.000247	0.0162	CbGpPWpGaD
Lacosamide—CA9—HIF-1-alpha transcription factor network—TERT—thyroid cancer	0.000246	0.0162	CbGpPWpGaD
Lacosamide—CA9—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	0.000235	0.0155	CbGpPWpGaD
Lacosamide—CA14—Metabolism—MINPP1—thyroid cancer	0.000199	0.0131	CbGpPWpGaD
Lacosamide—CA3—Metabolism—HPGD—thyroid cancer	0.000199	0.0131	CbGpPWpGaD
Lacosamide—CA6—Metabolism—MINPP1—thyroid cancer	0.000194	0.0127	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—MINPP1—thyroid cancer	0.000181	0.0119	CbGpPWpGaD
Lacosamide—CA14—Metabolism—NDUFA13—thyroid cancer	0.000169	0.0111	CbGpPWpGaD
Lacosamide—CA6—Metabolism—NDUFA13—thyroid cancer	0.000165	0.0108	CbGpPWpGaD
Lacosamide—CA14—Metabolism—CHST14—thyroid cancer	0.000159	0.0105	CbGpPWpGaD
Lacosamide—CA6—Metabolism—CHST14—thyroid cancer	0.000155	0.0102	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—NDUFA13—thyroid cancer	0.000154	0.0101	CbGpPWpGaD
Lacosamide—CA1—C-MYB transcription factor network—PTGS2—thyroid cancer	0.000148	0.00969	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—CHST14—thyroid cancer	0.000145	0.00951	CbGpPWpGaD
Lacosamide—CA4—Metabolism—MINPP1—thyroid cancer	0.000134	0.00879	CbGpPWpGaD
Lacosamide—CA1—C-MYB transcription factor network—CCND1—thyroid cancer	0.000133	0.00876	CbGpPWpGaD
Lacosamide—CA9—Cellular responses to stress—EPO—thyroid cancer	0.00013	0.00856	CbGpPWpGaD
Lacosamide—CA2—Metabolism—MINPP1—thyroid cancer	0.000128	0.00843	CbGpPWpGaD
Lacosamide—CA14—Metabolism—HPGD—thyroid cancer	0.000128	0.00843	CbGpPWpGaD
Lacosamide—SCN9A—Axon guidance—CDK1—thyroid cancer	0.000127	0.00833	CbGpPWpGaD
Lacosamide—CA6—Metabolism—HPGD—thyroid cancer	0.000125	0.00821	CbGpPWpGaD
Lacosamide—CA1—Metabolism—MINPP1—thyroid cancer	0.000123	0.00808	CbGpPWpGaD
Lacosamide—SCN3A—Axon guidance—CDK1—thyroid cancer	0.000121	0.00797	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—HPGD—thyroid cancer	0.000117	0.00767	CbGpPWpGaD
Lacosamide—CA1—C-MYB transcription factor network—NRAS—thyroid cancer	0.000115	0.00754	CbGpPWpGaD
Lacosamide—CA3—Metabolism—TPR—thyroid cancer	0.000114	0.00751	CbGpPWpGaD
Lacosamide—CA4—Metabolism—NDUFA13—thyroid cancer	0.000114	0.00748	CbGpPWpGaD
Lacosamide—CA3—Metabolism—PRKAR1A—thyroid cancer	0.000113	0.00739	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—CDK1—thyroid cancer	0.000112	0.00738	CbGpPWpGaD
Lacosamide—CA2—Metabolism—NDUFA13—thyroid cancer	0.000109	0.00717	CbGpPWpGaD
Lacosamide—CA9—Metabolism—MINPP1—thyroid cancer	0.000108	0.0071	CbGpPWpGaD
Lacosamide—CA4—Metabolism—CHST14—thyroid cancer	0.000107	0.00703	CbGpPWpGaD
Lacosamide—CA1—Metabolism—NDUFA13—thyroid cancer	0.000105	0.00687	CbGpPWpGaD
Lacosamide—CA2—Metabolism—CHST14—thyroid cancer	0.000103	0.00674	CbGpPWpGaD
Lacosamide—CA1—C-MYB transcription factor network—KRAS—thyroid cancer	9.88e-05	0.00649	CbGpPWpGaD
Lacosamide—CA1—Metabolism—CHST14—thyroid cancer	9.84e-05	0.00646	CbGpPWpGaD
Lacosamide—CA9—Metabolism—NDUFA13—thyroid cancer	9.2e-05	0.00604	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—CDK1—thyroid cancer	9.05e-05	0.00595	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—CDK1—thyroid cancer	8.66e-05	0.00569	CbGpPWpGaD
Lacosamide—CA9—Metabolism—CHST14—thyroid cancer	8.65e-05	0.00568	CbGpPWpGaD
Lacosamide—CA4—Metabolism—HPGD—thyroid cancer	8.63e-05	0.00567	CbGpPWpGaD
Lacosamide—CA3—Metabolism—SLC5A5—thyroid cancer	8.56e-05	0.00562	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—RXRA—thyroid cancer	8.4e-05	0.00552	CbGpPWpGaD
Lacosamide—CA1—C-MYB transcription factor network—HRAS—thyroid cancer	8.4e-05	0.00552	CbGpPWpGaD
Lacosamide—CA2—Metabolism—HPGD—thyroid cancer	8.27e-05	0.00543	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—RXRA—thyroid cancer	8.04e-05	0.00528	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—CDK1—thyroid cancer	8.02e-05	0.00527	CbGpPWpGaD
Lacosamide—CA1—Metabolism—HPGD—thyroid cancer	7.93e-05	0.00521	CbGpPWpGaD
Lacosamide—CA9—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	7.91e-05	0.00519	CbGpPWpGaD
Lacosamide—CA9—Cellular responses to stress—HIF1A—thyroid cancer	7.76e-05	0.0051	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—RXRA—thyroid cancer	7.45e-05	0.00489	CbGpPWpGaD
Lacosamide—CA14—Metabolism—TPR—thyroid cancer	7.37e-05	0.00484	CbGpPWpGaD
Lacosamide—CA14—Metabolism—PRKAR1A—thyroid cancer	7.25e-05	0.00476	CbGpPWpGaD
Lacosamide—CA3—Metabolism—RXRA—thyroid cancer	7.19e-05	0.00473	CbGpPWpGaD
Lacosamide—CA6—Metabolism—TPR—thyroid cancer	7.18e-05	0.00472	CbGpPWpGaD
Lacosamide—CA6—Metabolism—PRKAR1A—thyroid cancer	7.07e-05	0.00464	CbGpPWpGaD
Lacosamide—CA9—Metabolism—HPGD—thyroid cancer	6.97e-05	0.00458	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—TPR—thyroid cancer	6.71e-05	0.0044	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—PRKAR1A—thyroid cancer	6.6e-05	0.00433	CbGpPWpGaD
Lacosamide—CA14—Metabolism—SLC5A5—thyroid cancer	5.52e-05	0.00362	CbGpPWpGaD
Lacosamide—CA6—Metabolism—SLC5A5—thyroid cancer	5.38e-05	0.00353	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—PPARG—thyroid cancer	5.3e-05	0.00348	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—PPARG—thyroid cancer	5.07e-05	0.00333	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—SLC5A5—thyroid cancer	5.02e-05	0.0033	CbGpPWpGaD
Lacosamide—CA4—Metabolism—TPR—thyroid cancer	4.95e-05	0.00325	CbGpPWpGaD
Lacosamide—CA4—Metabolism—PRKAR1A—thyroid cancer	4.87e-05	0.0032	CbGpPWpGaD
Lacosamide—CA2—Metabolism—TPR—thyroid cancer	4.75e-05	0.00312	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—PPARG—thyroid cancer	4.7e-05	0.00309	CbGpPWpGaD
Lacosamide—CA2—Metabolism—PRKAR1A—thyroid cancer	4.67e-05	0.00307	CbGpPWpGaD
Lacosamide—CA14—Metabolism—RXRA—thyroid cancer	4.64e-05	0.00304	CbGpPWpGaD
Lacosamide—CA1—Metabolism—TPR—thyroid cancer	4.55e-05	0.00299	CbGpPWpGaD
Lacosamide—SCN9A—Axon guidance—NRAS—thyroid cancer	4.55e-05	0.00299	CbGpPWpGaD
Lacosamide—CA3—Metabolism—PPARG—thyroid cancer	4.54e-05	0.00298	CbGpPWpGaD
Lacosamide—CA6—Metabolism—RXRA—thyroid cancer	4.52e-05	0.00297	CbGpPWpGaD
Lacosamide—CA1—Metabolism—PRKAR1A—thyroid cancer	4.48e-05	0.00294	CbGpPWpGaD
Lacosamide—SCN3A—Axon guidance—NRAS—thyroid cancer	4.35e-05	0.00286	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—RXRA—thyroid cancer	4.22e-05	0.00277	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—NRAS—thyroid cancer	4.03e-05	0.00265	CbGpPWpGaD
Lacosamide—CA9—Metabolism—TPR—thyroid cancer	4e-05	0.00263	CbGpPWpGaD
Lacosamide—CA9—Metabolism—PRKAR1A—thyroid cancer	3.94e-05	0.00259	CbGpPWpGaD
Lacosamide—SCN9A—Axon guidance—KRAS—thyroid cancer	3.92e-05	0.00257	CbGpPWpGaD
Lacosamide—SCN3A—Axon guidance—KRAS—thyroid cancer	3.75e-05	0.00246	CbGpPWpGaD
Lacosamide—CA4—Metabolism—SLC5A5—thyroid cancer	3.71e-05	0.00244	CbGpPWpGaD
Lacosamide—CA3—Metabolism—PTGS2—thyroid cancer	3.57e-05	0.00235	CbGpPWpGaD
Lacosamide—CA2—Metabolism—SLC5A5—thyroid cancer	3.56e-05	0.00234	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—KRAS—thyroid cancer	3.47e-05	0.00228	CbGpPWpGaD
Lacosamide—CA1—Metabolism—SLC5A5—thyroid cancer	3.41e-05	0.00224	CbGpPWpGaD
Lacosamide—SCN9A—Axon guidance—HRAS—thyroid cancer	3.33e-05	0.00219	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—NRAS—thyroid cancer	3.25e-05	0.00213	CbGpPWpGaD
Lacosamide—SCN3A—Axon guidance—HRAS—thyroid cancer	3.18e-05	0.00209	CbGpPWpGaD
Lacosamide—CA3—Metabolism—PTEN—thyroid cancer	3.12e-05	0.00205	CbGpPWpGaD
Lacosamide—CA4—Metabolism—RXRA—thyroid cancer	3.12e-05	0.00205	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—NRAS—thyroid cancer	3.11e-05	0.00204	CbGpPWpGaD
Lacosamide—CA9—Cellular responses to stress—TP53—thyroid cancer	3.09e-05	0.00203	CbGpPWpGaD
Lacosamide—CA9—Metabolism—SLC5A5—thyroid cancer	3e-05	0.00197	CbGpPWpGaD
Lacosamide—CA2—Metabolism—RXRA—thyroid cancer	2.99e-05	0.00196	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—HRAS—thyroid cancer	2.95e-05	0.00194	CbGpPWpGaD
Lacosamide—CA14—Metabolism—PPARG—thyroid cancer	2.93e-05	0.00192	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—NRAS—thyroid cancer	2.88e-05	0.00189	CbGpPWpGaD
Lacosamide—CA1—Metabolism—RXRA—thyroid cancer	2.86e-05	0.00188	CbGpPWpGaD
Lacosamide—CA6—Metabolism—PPARG—thyroid cancer	2.85e-05	0.00187	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—KRAS—thyroid cancer	2.79e-05	0.00184	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—KRAS—thyroid cancer	2.67e-05	0.00176	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—PPARG—thyroid cancer	2.66e-05	0.00175	CbGpPWpGaD
Lacosamide—CA9—Metabolism—RXRA—thyroid cancer	2.52e-05	0.00165	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—KRAS—thyroid cancer	2.48e-05	0.00163	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—HRAS—thyroid cancer	2.38e-05	0.00156	CbGpPWpGaD
Lacosamide—CA14—Metabolism—PTGS2—thyroid cancer	2.3e-05	0.00151	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—HRAS—thyroid cancer	2.27e-05	0.00149	CbGpPWpGaD
Lacosamide—CA6—Metabolism—PTGS2—thyroid cancer	2.24e-05	0.00147	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—HRAS—thyroid cancer	2.1e-05	0.00138	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—AKT1—thyroid cancer	2.1e-05	0.00138	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—PTGS2—thyroid cancer	2.09e-05	0.00138	CbGpPWpGaD
Lacosamide—CA14—Metabolism—PTEN—thyroid cancer	2.01e-05	0.00132	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—AKT1—thyroid cancer	2.01e-05	0.00132	CbGpPWpGaD
Lacosamide—CA4—Metabolism—PPARG—thyroid cancer	1.97e-05	0.00129	CbGpPWpGaD
Lacosamide—CA6—Metabolism—PTEN—thyroid cancer	1.96e-05	0.00129	CbGpPWpGaD
Lacosamide—CA2—Metabolism—PPARG—thyroid cancer	1.89e-05	0.00124	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—AKT1—thyroid cancer	1.86e-05	0.00122	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—PTEN—thyroid cancer	1.83e-05	0.0012	CbGpPWpGaD
Lacosamide—CA1—Metabolism—PPARG—thyroid cancer	1.81e-05	0.00119	CbGpPWpGaD
Lacosamide—CA3—Metabolism—AKT1—thyroid cancer	1.8e-05	0.00118	CbGpPWpGaD
Lacosamide—CA9—Metabolism—PPARG—thyroid cancer	1.59e-05	0.00104	CbGpPWpGaD
Lacosamide—CA4—Metabolism—PTGS2—thyroid cancer	1.55e-05	0.00102	CbGpPWpGaD
Lacosamide—CA2—Metabolism—PTGS2—thyroid cancer	1.48e-05	0.000975	CbGpPWpGaD
Lacosamide—CA1—Metabolism—PTGS2—thyroid cancer	1.42e-05	0.000934	CbGpPWpGaD
Lacosamide—CA4—Metabolism—PTEN—thyroid cancer	1.35e-05	0.000886	CbGpPWpGaD
Lacosamide—CA2—Metabolism—PTEN—thyroid cancer	1.29e-05	0.00085	CbGpPWpGaD
Lacosamide—CA9—Metabolism—PTGS2—thyroid cancer	1.25e-05	0.000821	CbGpPWpGaD
Lacosamide—CA1—Metabolism—PTEN—thyroid cancer	1.24e-05	0.000815	CbGpPWpGaD
Lacosamide—CA14—Metabolism—AKT1—thyroid cancer	1.16e-05	0.00076	CbGpPWpGaD
Lacosamide—CA6—Metabolism—AKT1—thyroid cancer	1.13e-05	0.000741	CbGpPWpGaD
Lacosamide—CA9—Metabolism—PTEN—thyroid cancer	1.09e-05	0.000716	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—AKT1—thyroid cancer	1.05e-05	0.000692	CbGpPWpGaD
Lacosamide—CA4—Metabolism—AKT1—thyroid cancer	7.78e-06	0.000511	CbGpPWpGaD
Lacosamide—CA2—Metabolism—AKT1—thyroid cancer	7.46e-06	0.00049	CbGpPWpGaD
Lacosamide—CA1—Metabolism—AKT1—thyroid cancer	7.15e-06	0.00047	CbGpPWpGaD
Lacosamide—CA9—Metabolism—AKT1—thyroid cancer	6.29e-06	0.000413	CbGpPWpGaD
